Cochin Cancer Research Centre

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

11 Stories Indexed

Last Updated: Just Now

Verified Entity Intelligence

National Governance & Policy 01 Nov 2026, 02:00 PM IST

Cochin Cancer Research Centre to Be Built Into Centre of Excellence, Says Chief Minister V.D. Satheesan

The Cochin Cancer Research Centre will be developed into a centre of excellence under a five-year plan to be rolled out in phases, Chief Minister V.D. Satheesan said on Tuesday. The announcement signals a structured push to strengthen cancer care infrastructure, research capacity and specialised treatment delivery in Kerala.

By RDU Global Wire5 min read

Macro Economy & Fiscal Policy09 Oct 2026, 06:59 PM IST

Cochin Shipyard Begins Steel Cutting for 70-Tonne Tug Order from Svitzer Denmark

Cochin Shipyard has marked the start of construction on a new series of 70-tonne bollard pull tugs for Svitzer A/S of Denmark, a contract that underscores India’s growing role in specialised maritime manufacturing. The TRAnsverse-class vessels are designed for demanding close-quarter operations and are expected to serve a wide range of ship types in difficult weather and tidal conditions.

5 min readRead →

Macro Economy & Fiscal Policy09 Oct 2026, 03:29 PM IST

Cochin Shipyard Begins Steel Cutting for 70-Tonne Bollard Pull Tugs for Svitzer A/S

Cochin Shipyard has commenced steel cutting for a new series of 70-tonne bollard pull tugs being built for Svitzer A/S of Denmark, marking a fresh export-linked order for India’s shipbuilding sector. The TRAnsverse-class vessels are designed for demanding close-quarter operations and are intended to serve a wide range of ship sizes and operating conditions, including difficult weather and tidal environments.

6 min readRead →

National Governance & Policy09 Oct 2026, 02:12 AM IST

Cusat shifts classes online as chickenpox cases surge, postpones exams

Cochin University of Science and Technology has moved all classes on its Thrikkakara and Marine campuses online until October 16 after a sharp rise in chickenpox infections among students. The university has also asked infected students to leave hostels and postponed scheduled examinations as it moves to contain further spread.

4 min readRead →

Macro Economy & Fiscal Policy06 Oct 2026, 08:07 AM IST

CIAL’s User Fee Draws Scrutiny as Kochi Airport Expansion Needs Come Into Focus

The user fee at Kochi’s airport operator, Cochin International Airport Ltd., is facing renewed scrutiny amid questions over whether passengers are paying for routine operations rather than long-term capacity expansion. Critics argue the levy would be easier to justify if it were clearly tied to a second runway, a project that could strengthen the airport’s future growth case. The debate highlights a broader policy tension in Indian aviation: how airports balance user charges, infrastructure financing and public acceptance.

6 min readRead →

Macro Economy & Fiscal Policy05 Oct 2026, 08:28 PM IST

CIAL User Fee Faces Renewed Scrutiny as Critics Question Airport Priorities

The user fee collected at Kochi’s Cochin International Airport Ltd. is drawing fresh scrutiny amid questions over whether passengers should continue paying without a clearer long-term infrastructure payoff. Critics argue the levy would be easier to justify if the airport authority were using it to finance a second runway, a project seen as central to future capacity and operational resilience.

5 min readRead →

Global Health & Biotech26 Oct 2026, 08:00 PM IST

Landmark Melanoma Vaccine Trial Cuts Recurrence or Death Risk by 42%, Raising Stakes for Cancer Biotech

A first-of-its-kind personalized cancer vaccine has reduced the risk of melanoma recurrence or death by 42% in a landmark trial, according to reports from the European Society for Medical Oncology meeting. The result strengthens the case for individualized immunotherapy and could reshape investor expectations for Moderna, Merck, and the broader oncology biotech sector.

4 min readRead →

World Politics & Diplomacy26 Oct 2026, 02:00 PM IST

Vanessa Trump Says She Is Cancer-Free Six Months After Breast Cancer Diagnosis

Vanessa Trump, the former wife of Donald Trump Jr., says she is cancer-free six months after publicly revealing that she had been diagnosed with breast cancer. Her announcement adds a personal health update to a family long watched through the lens of American politics and public scrutiny. The disclosure, made months after her initial diagnosis in May, underscores the private toll of a disease that affects millions while drawing renewed attention to the intersection of celebrity, family life, and public resilience.

5 min readRead →

Global Markets & Equities25 Oct 2026, 08:00 AM IST

Tango Reports 82% Tumor Response in Pancreatic Cancer Trial, Raising the Stakes in a Crowded Race

Tango Therapeutics said its combination therapy produced an 82% tumor response rate in an early-stage trial involving advanced pancreatic cancer, a result that could sharpen investor attention on one of oncology’s most difficult targets. The data add momentum to the company’s strategy, while also inviting scrutiny over durability, patient selection and whether the response can translate into a meaningful late-stage commercial opportunity.

5 min readRead →

World Politics & Diplomacy18 Oct 2026, 08:00 PM IST

Pope Leo XIV Thanks Well-Wishers in First Public Appearance After Lung Cancer Surgery

Pope Leo XIV made his first public appearance since undergoing surgery for lung cancer, reciting the traditional Angelus prayer from the balcony of the Apostolic Palace and thanking supporters for their prayers. The appearance, closely watched by the global Catholic community, signaled both a personal recovery milestone and a carefully managed return to public ministry.

6 min readRead →

Global Health & Biotech15 Oct 2026, 09:30 PM IST

Merck CEO Says Personalized Cancer Vaccine Could Be Made Faster as Pipeline Advances

Merck Chief Executive Robert Davis told CNBC he expects the company’s experimental personalized cancer vaccine to become faster to manufacture over time, signaling a potential shift from early-stage scientific promise toward more scalable production. The comments add fresh attention to a closely watched oncology program that investors view as a possible long-term growth driver for Merck and a broader test case for the commercial viability of personalized cancer immunotherapy.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Cochin Cancer Research Centre:

V.D. Satheesan(1)Kerala(1)